You are here: Industry Insights > GSK

News List

GSK buys stake in Vir Biotechnology in search of Covid-19 therapies pharmaceutical-technology
April 08, 2020
GlaxoSmithKline (GSK) has agreed to invest $250m in Vir Biotechnology for the research and development (R&D) of antibodies to treat Covid-19 infection.
GSK's Nucala shows promise in nasal polyps pharmatimes
April 07, 2020
GlaxoSmithKline has reported positive late-stage data showing the benefit of its biologic Nucala (mepolizumab) in patients with nasal polyps in patient requiring further surgeries for the condition.
GSK partners with Innovax Biotech on Covid-19 vaccine pharmaceutical-technology
April 07, 2020
GlaxoSmithKline (GSK) has partnered with Xiamen Innovax Biotech to support the development of a recombinant protein-based vaccine candidate against Covid-19.
Cipla announces completion of phase-3 clinical study for generic version of GSK’s Advair Diskus expresspharma
April 03, 2020
The study, completed in the first attempt, was conducted over a period of 15 months at over 100 sites in the US enrolling 1,400 asthma patients.
Angelini Pharma Acquires ThermaCare from GSK americanpharmaceuticalreview
March 11, 2020
Angelini Pharma has acquired the ThermaCare® global business rights, excluding North America, from GSK. The deal also includes the dedicated US manufacturing site for ThermaCare in Albany, Georgia.
GSK, Immatics team up for cancer cell therapies pharmatimes
March 10, 2020
Immatics Biotechnologies has announced a new strategic collaboration with GlaxoSmithKline (GSK), in order to develop novel adoptive cell therapies targeting multiple cancer indications.
Bora Pharmaceuticals to Acquire GSK Mississauga-based Facility contractpharma
March 10, 2020
Bora Pharmaceuticals and GSK have entered into an agreement under which Bora will acquire GSK’s Mississauga, Ontario (Canada) facility.
Trelegy Ellipta filing accepted by EMA for asthma pharmatimes
March 06, 2020
The European Medicines Agency (EMA) has accepted GlaxoSmithKline’s regulatory submission seeking an additional indication for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the treatment of asthma.
FDA approves GSK’s Advil Dual Action with Acetaminophen OTC pain reliever pharmaceutical-business-review
March 06, 2020
GlaxoSmithKline (GSK) has secured approval for Advil Dual Action with Acetaminophen from the US Food and Drug Administration (FDA) as an over-the-counter (OTC) product for pain relief.
STADA agrees to buy 15 consumer healthcare brands from GSK pharmaceutical-technology
March 04, 2020
Germany-based STADA has agreed to buy a portfolio of 15 consumer healthcare brands from GlaxoSmithKline (GSK) in European countries, including Germany, France, Poland, Italy, Russia, Spain and Switzerland.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page